Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use.
about
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromesAcute kidney injury: emerging pharmacotherapies in current clinical trials.Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST).Safety and pharmacokinetics of the oral iron chelator SP-420 in β-thalassemia.
P2860
Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Transfusion-dependent thalassa ...... ndrome due to deferasirox use.
@en
type
label
Transfusion-dependent thalassa ...... ndrome due to deferasirox use.
@en
prefLabel
Transfusion-dependent thalassa ...... ndrome due to deferasirox use.
@en
P2093
P2860
P50
P356
P1433
P1476
Transfusion-dependent thalassa ...... ndrome due to deferasirox use.
@en
P2093
Gwo-Tsann Chuang
Meng-Yao Lu
Yong-Kwei Tsau
P2860
P304
P356
10.1111/NEP.12523
P577
2015-05-28T00:00:00Z